Overexpression of DNMT1 and DNMT3A is associated with aggressive behavior…
Ma, Hou-Shi Zhejiang Sci-Tech University|Yangtze Delta Region Institute of Tsinghua University
Wang, Elaine Lu University of Tokushima|Kanazawa Medical University
Xu, Wen-Fei Yangtze Delta Region Institute of Tsinghua University
Yamada, Shozo Toranomon Hospital
Yoshimoto, Katsuhiko University of Tokushima Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Qian, Zhi Rong Harvard Medical School
Shi, Long Yangtze Delta Region Institute of Tsinghua University
Liu, Li-Li Zhejiang Sci-Tech University
Li, Xu-Hui Yangtze Delta Region Institute of Tsinghua University
Genes, Tumor Suppressor
BACKGROUND: Alteration of DNA methylation of tumor suppressor genes (TSGs) is one of the most consistent epigenetic changes in human cancers. DNMTs play several important roles in DNA methylation and development of cancers. Regarding DNMTs protein expressions, little is known about the clinical significance and correlation with promoter methylation status of TSGs in human pituitary adenomas.
MATERIAL AND METHODS: We analyzed the protein expression of 3 DNMTs using immunohistochemistry and assessed DNA hypermethylation of RASSF1A, CDH13, CDH1, and CDKN2A (p16) in 63 pituitary adenomas. We examined associations between DNMTs expression and clinicopathological features or promoter methylation status of TSGs.
RESULTS: Overexpression of DNMTs was detected in pituitary adenomas. Frequencies of DNMT1 overexpression were significantly higher in macroadenomas, invasive tumors, and grade III and IV tumors. DNMT3A was frequently detected in invasive tumors and grade IV tumors. In addition, DNMT1 and DNMT3A were frequently detected in high-methylation tumors. Furthermore, in multivariate logistic regression, the significant association between DNMT1 or DNMT3A and high-methylation status persisted after adjusting for clinicopathological features.
CONCLUSIONS: Our findings suggested that tumor overexpression of DNMT1 and DNMT3A is associated with tumor aggressive behavior and high-methylation status in pituitary adenomas. Our data support a possible role of DNMT1 and DNMT3A in TSG promoter methylation leading to pituitary adenoma invasion and suggest that inhibition of DNMTs has the potential to become a new therapeutic approach for invasive pituitary adenoma.
Medical Science Monitor
International Scientific Information
© Med Sci Monit, 2018. This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).
|DOI (Published Version)|
|URL ( Publisher's Version )|
medscimonit_24_4841.pdf 229 KB